BIOMEDOMICS, INC. — Department of Health and Human Services SBIR Phase II: The overall objective of this proposal is to develop a novel, simple, low-cost, on-site DO
BIOMEDOMICS, INC. — SBIR Phase II award from Department of Health and Human Services.
- Amount
- $745,047
- Agency
- Department of Health and Human Services · National Institutes of Health
- Program / Phase
- SBIR · Phase II
- NAICS
- —
- Place of performance
- NC
- Period
- —
Description
The overall objective of this proposal is to develop a novel, simple, low-cost, on-site DOA test device and kit for measuring drugs of abuse for multiplex analysis capabilities based on the Contractor's patented ultra-sensitive Time-Resolved Luminescent Lateral Flow Assay Technology with digital reader. In order to make such a device available, the Contractor will research on multiplex lateral flow immunoassay (MLFIA) strip design and fabrication, as well as detection device development. The Contractor willalso establish a time-resolved MLFIA technology platform which includes new components on novel nanoparticles, and time-resolved detection.